Skip to main content
Izotropic Corporation logo

Izotropic Corporation — Investor Relations & Filings

Ticker · IZO LEI · 529900IZ5PIVM7X6S027 CSE Manufacturing
Open in API
Filings indexed 206 across all filing types
Latest filing 2026-04-21 Regulatory Filings
Country CA Canada
Listing CSE IZO

About Izotropic Corporation

https://izocorp.com/

Izotropic Corporation develops and commercializes diagnostic medical devices, specializing in advanced breast cancer detection technology. Its flagship product is IzoView, a dedicated Breast CT imaging platform. IzoView utilizes high-resolution, true 3D imaging without requiring breast compression, offering superior spatial resolution compared to traditional modalities. The system is purpose-built to improve diagnostic accuracy and patient comfort, particularly targeting the 50% of women with dense breast tissue where conventional screening tools are often inadequate. Izotropic is currently advancing IzoView through pivotal clinical studies toward product launch and commercialization.

Recent filings

Filing Released Lang Actions
Report of exempt distribution (45-106F1).pdf
Regulatory Filings Classification · 1% confidence The document is a filled-in Canadian securities regulatory form titled “Form 45-106F1 Report of Exempt Distribution,” containing detailed statutory disclosure under National Instrument 45-106. It is not an annual, interim, management report, earnings release, or investor presentation but a mandatory regulatory filing for an exempt securities distribution. There is no specific category for this form, so it falls into the general Regulatory Filings category (RNS).
2026-04-21 English
Report of exempt distribution (45-106F1).pdf
Regulatory Filings Classification · 1% confidence The provided document is a Canadian securities regulatory form (Form 45-106F1) titled “Report of Exempt Distribution,” filed under National Instrument 45-106. It details a prospectus‐exempt securities distribution (dates, purchasers, exemptions, compensation, etc.). This is neither a financial statement (10-K, IR), an earnings release, board change notice, capital market update, nor any other specific corporate report category. It is a regulatory filing reporting details of an exempt distribution, which falls under the fallback category “Regulatory Filings (RNS).”
2026-04-21 English
News release - English.pdf
Capital/Financing Update Classification · 1% confidence The document is a corporate press release announcing a debt settlement agreement and the issuance of shares and warrants to settle indebtedness. This constitutes a financing activity and capital structure change rather than an earnings report, management change, or regulatory notice. It therefore best fits the Capital/Financing Update category.
2026-04-21 English
News release - English.pdf
Capital/Financing Update Classification · 1% confidence The document is a corporate announcement describing a debt settlement agreement involving the issuance of equity units (shares and warrants) to settle a portion of a promissory note. This represents a financing activity and capital structure change rather than a regulatory filing, earnings release, or management change. Therefore it falls under Capital/Financing Update.
2026-04-21 English
Report of exempt distribution (45-106F1).pdf
Delisting Announcement Classification · 1% confidence The document is an official announcement from Rackla Metals Inc. regarding a notice from the TSX Venture Exchange that the company is at risk of being transferred to the NEX board due to failing to meet continued listing requirements. This is a direct notification regarding the status of the company's listing on an exchange, which falls under the definition of a delisting-related announcement.
2026-02-09 English
Material change report - English.pdf
Regulatory Filings Classification · 1% confidence The document is a 'Form 45-106F1 Report of Exempt Distribution', which is a specific regulatory filing used in Canada to report the distribution of securities that are exempt from the prospectus requirement. This document details capital raising activities (issuance of securities). Since it is a regulatory filing regarding capital distribution and does not fit into the other specific categories like 10-K or IR, it is best classified as a Regulatory Filing (RNS).
2026-02-04 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.